Welcome to the tag category page for Kidney disease!
EGFR (estimated glomerular filtration rate) is a measure of how well the kidneys are working in filtering waste from the blood. The normal eGFR for adults is usually more than 90, but it declines with age even in people without kidney disease. A very low eGFR may indicate kidney failure. An eGFR test is used to evaluate kidney function, clinically. eGFR is an estimated number based on a blood test and age, sex, body type, and race. For patients younger than 40 years, CKD is defined by eGFR below 75 mL/min/1.73m2, for patients with ages between 40 and 65 years, CKD is defined by 60 mL/min/1.73m2. It is essential to know the cause of kidney disease and check the kidney function to plan treatment in case an eGFR falls below 60 for three months or more.
Wet Cat Food is a type of cat food that is high in moisture content and is typically packaged in cans or pouches. It is recommended by veterinarians because it helps keep cats hydrated and can prevent kidney disease. Wet food is easier for cats to digest than dry food, and it may contain a higher proportion of protein, which is essential for cats. While not necessary, wet food is generally preferred by many cat owners because it provides better hydration and more variety for their pet's diet. Some of the best wet cat food brands are Purina Pro Plan, Sheba, and Friskies. Overall, wet food is an important part of a cat's diet and should be included in their daily meals.
SGLT, or sodium-glucose transport proteins, are a family of glucose transporters found in the intestinal mucosa and renal proximal convoluted tubules. SGLT2 inhibitors are a class of medication used to treat type 2 diabetes by blocking the reabsorption of glucose in the kidneys and promoting its excretion in the urine. Common examples of SGLT2 inhibitors include Invokana, Farxiga, Jardiance, and Steglatro. SGLT1 is responsible for glucose absorption in the small intestine and reabsorbing about 3% of the filtered glucose load in the renal proximal tubule segment 3. SGLT2, on the other hand, is responsible for the majority of glucose reuptake in the tubular system of the kidney. SGLT2 inhibitors are versatile medications with glycemic and nonglycemic benefits that help lower blood sugar levels in adults with type 2 diabetes.
